🔴 Thermo Fisher Scientific is trading 4.04% down in pre-market despite Q3 beat and raised 2026 outlook

Thermo Fisher Scientific is trading at $659.57, down 4.04%, despite reporting Q3 results above analyst estimates and raising its 2026 adjusted EPS outlook.

• Q3 revenue was $12.14 billion and adjusted EPS was $6.68.
• Shares are below the October 20 close of $687.37.
• Available reporting does not establish why shares are falling; no specific negative catalyst or trading-volume details were found.